Bayer is a world leader in innovation with core competencies in the fields
of health care and agriculture. Bayer develops new molecules for use in innovative
products and solutions to improve the health of humans, animals and plants. Its
research and development activities are based on a profound understanding of the
biochemical processes in living organisms. Through its products, Bayer is contributing
to finding solutions to some of the major challenges of our time.
The growing and increasingly aging world population requires improved
medical care and an adequate supply of food. Bayer is improving people’s
quality of life by preventing, alleviating and curing diseases and the company
is helping provide a reliable supply of high-quality food, feed and plant-based
Bayer’s links with China have a long tradition, going back to 1882 when the
company first came to China. With the country now among the fastest-growing
markets in the world, Bayer has stepped up its involvement in the region. Today,
Greater China (Mainland, Hong Kong, Taiwan) is Bayer's largest single market in Asia.
By the end of 2017, about 10,000 people were employed by Bayer in Greater China.
Bayer is represented in Greater China by its three business divisions: Pharmaceuticals,
Consumer Health and Crop Science, and operates several production facilities.
Bayer started producing Aspirin in Shanghai as early as 1936, and now local
production accounts for an increasing proportion of sales in Greater China.
With a number of major investments under way, Bayer is positioned to be a key
engine in China’s development.